571 related articles for article (PubMed ID: 25013375)
1. Recent advances in drug repositioning for the discovery of new anticancer drugs.
Shim JS; Liu JO
Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
3. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
4. Computational drug repositioning for cancer therapeutics.
Jiao M; Liu G; Xue Y; Ding C
Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
[TBL] [Abstract][Full Text] [Related]
5. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
6. Computational Drug Repurposing: Current Trends.
Karaman B; Sippl W
Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
[TBL] [Abstract][Full Text] [Related]
7. Double Repositioning: Veterinary Antiparasitic to Human Anticancer.
Sultana T; Jan U; Lee JI
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457127
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Drug Repurposing for Parkinson's Disease.
Chen X; Gumina G; Virga KG
Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
[TBL] [Abstract][Full Text] [Related]
9. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in drug repurposing using machine learning.
Urbina F; Puhl AC; Ekins S
Curr Opin Chem Biol; 2021 Dec; 65():74-84. PubMed ID: 34274565
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Drug Discovery By Structure-Based Repositioning Approach.
Modh DH; Kulkarni VM
Mini Rev Med Chem; 2024; 24(1):60-91. PubMed ID: 37165589
[TBL] [Abstract][Full Text] [Related]
12. Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy.
Li CL; Fang ZX; Wu Z; Hou YY; Wu HT; Liu J
Biomed Pharmacother; 2022 Oct; 154():113616. PubMed ID: 36055112
[TBL] [Abstract][Full Text] [Related]
13. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.
Veschi S; De Lellis L; Florio R; Lanuti P; Massucci A; Tinari N; De Tursi M; di Sebastiano P; Marchisio M; Natoli C; Cama A
J Exp Clin Cancer Res; 2018 Sep; 37(1):236. PubMed ID: 30241558
[TBL] [Abstract][Full Text] [Related]
14. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
15. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
16. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
17. A survey of current trends in computational drug repositioning.
Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
[TBL] [Abstract][Full Text] [Related]
18. Repurposing antidepressants for anticancer drug discovery.
Song Y; Yang X; Yu B
Drug Discov Today; 2022 Jul; 27(7):1924-1935. PubMed ID: 34728374
[TBL] [Abstract][Full Text] [Related]
19. Revisiting Non-Cancer Drugs for Cancer Therapy.
Yang EJ; Wu C; Liu Y; Lv J; Sup Shim J
Curr Top Med Chem; 2016; 16(19):2144-55. PubMed ID: 26881712
[TBL] [Abstract][Full Text] [Related]
20. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
